Using a specific MSH2 mutant in which NPM-ALK-mediated p-Y of MSH2 is largely abrogated, we assessed whether this newly described phosphorylation event underlies the NPM-ALK-induced MMR deficiency. This evidence concerns the gene ALK and mismatch repair cancer syndrome 1.